NCT05387733: A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With Dercum's Disease Lipomas |
|
|
| Completed | 2a | 12 | US | 10 mg CBL-514 per injection, 15 mg CBL-514 per injection | Caliway Biopharmaceuticals Co., Ltd. | Dercum's Disease | 04/23 | 04/23 | | |
NCT06549738: Effects of Intermittent Pneumatic Compression Therapy on Tissue Volume, Pain, and Quality of Life in Lipedema |
|
|
| Completed | N/A | 46 | US | Intermittent pneumatic compression therapy, Lympha Press, Lympha Press Optimal Plus, HCPCS code E0652, pneumatic compression, lymphedema pump | Lympha Press, Carolina Vein Center | Lipedema | 11/23 | 11/23 | | |